Imunon, Inc. (IMNN) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Please stand by. Good morning. My name is Desiree and I will be your operator today. At this time, I would like to welcome you to Immunon's fourth quarter and full year 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. Following the speaker's prepared remarks, there will be a question and answer session. You may press star 1 on your phone to ask a question at this time. Please keep in mind, if you are using a speakerphone, you must release your mute function to allow the signal to reach our equipment. Again, that's star 1 to ask a question during the Q&A session. I would now like to turn the call over to Peter Vozzo of ICR Healthcare, Investor Relations Representative for Immunon. Please go ahead. Thank you, Desiree. Good morning, everyone, and welcome to Immunon's fourth quarter and full year 2025 financial results and business update conference call. During today's call, management will be making forward-looking statements regarding Immunon's expectations and projections about future events. In general, forward-looking statements can be identified by the words such as expects, anticipates, believes, or other similar expressions. These statements are based on current expectations and are subject to a number of risks and uncertainties, including those set forth in the company's periodic filings with the Securities and Exchange Commission. No forward-looking statements can be guaranteed, and actual results may differ materially from those such statements. I also caution that the content of this conference call is accurate only as of the date of the live broadcast, March 31, 2026. Immunon undertakes no obligation to revise or update comments made during this call, except as required by law. With that said, I wou...